 |
Made up of twelve professors and European doctors
specialising in Neurosciences and representing both
public and private research equally, as well as new
and innovative companies, the scientific committee
includes the following experts:
|
- Dr. Silvano Fumero, CEO and founder
of Creabilis
therapeutics.
- Dr. Fulvio Uggeri, Director, Milano
Research Centre at Bracco S.p.A., now Bracco Imaging S.p.A.
- Prof. Mauro Fasano, Vice-director
of the Department of Structural and Functional Biology
of the University of Insubria, scientific secretary of
the Centre of Neuroscience at the same university, vice-president
of the Italian NMR discussion group, president-elect of
the life science division of the Italian Chemical Society.
- Prof. Piergiorgio Strata, Professor
of Neurophysiology in University of Turin, Director of
the Rita Levi Montalcini Center for Brain Repair and President
of the Consortium named Istituto Nazionale di Neuroscienze.
- Prof. Leonardo Lopiano, Full Professor
in Neurology at the Neuroscience Department of the University
of Torino.
- Prof. Ann Kato, Department of Basic
Neuroscience, Faculty of Medicine, University of Geneva
and President of the Swiss Committee for the organisation
of the Federation of European Meeting of Neurosciences
(FENS) in Geneva in 2008.
- Prof Pierre Magistretti, Director of
the Psychiatric Neurosciences Center of the University
of Lausanne and university hospitals and co-director of
the Brain and Mind Institute of the Federal School of
Technology, Lausanne, EPFL.
- Dr. Laurent Choppe, General Manager
Neurochem
International Ltd , Lausanne
- Dr. Andrea Pfeifer, CEO-Founder AC
Immune
- Dr. Johan Luthman, Head of Neuroscience,
SERONO
- Prof. Michel Jouvet, he was Director
of the Department of Experimental Medicine at the Faculty
of Medicine, Claude Bernard University of Lyon (France).
- Prof. Claude Feuerstein, Consultant
for Life Sciences and Health by the Director of Higher
Education at the Ministry of State Education, Higher Education
and Research, Scientific Coordinator of the cluster settled
by Rhône-Alpes Region and entitled « Handicap,
Ageing, Neurosciences ».
- Xavier Priquel Ph. D, CEO and founder
of ISIS
SAS
- Hervé Perron, bioMérieux,
Senior Research Director Neurological diseases Unit
:: Download
full committee description :: |
